CPC C12N 15/113 (2013.01) [A61P 21/00 (2018.01); C12Q 1/6883 (2013.01); C12N 2310/141 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01)] | 4 Claims |
1. A method for treating a muscle disease
wherein the muscle disease is caused by a SOD1 or a dystrophin gene mutation, the method including: administering a composition comprising a pharmaceutically effective amount of miR-18b to a subject, wherein the muscle disease caused by a SOD1 or a dystrophin gene mutation is selected from the group consisting of Duchenne muscular dystrophy, Becker muscular dystrophy, SOD1-associated muscular atrophy, and amyotrophic lateral sclerosis.
|